Kazunari Aoki, Mizuki Hyuga, Yusuke Tarumoto, Gohei Nishibuchi, Atsushi Ueda, Yotaro Ochi, Seiichi Sugino, Takashi Mikami, Hirokazu Kobushi, Itaru Kato, et al. Canonical BAF complex regulates the oncogenic program in human T-cell acute lymphoblastic leukemia. Blood. 2024. 143. 7. 604-618
Takaaki Konuma, Hidehiro Itonaga, Yoshimitsu Shimomura, Machiko Fujioka, Kazunari Aoki, Naoyuki Uchida, Makoto Onizuka, Atsushi Jinguji, Masatsugu Tanaka, Yasunori Ueda, et al. Single-unit unrelated cord blood transplantation versus HLA-matched sibling transplantation in adults with advanced myelodysplastic syndrome: A registry-based study from the adult MDS working group of the Japanese society for transplantation and cellular therapy. Hematological oncology. 2023
Hidehiro Itonaga, Yasushi Miyazaki, Kazunari Aoki, Naoki Shingai, Yukiyasu Ozawa, Takahiro Fukuda, Keisuke Kataoka, Toshiro Kawakita, Yasunori Ueda, Takahide Ara, et al. Allogeneic transplantation of bone marrow versus peripheral blood stem cells from HLA-identical relatives in patients with myelodysplastic syndromes and oligoblastic acute myeloid leukemia: a propensity score analysis of a nationwide database. Annals of hematology. 2023
Yoshiki Omatsu, Shota Aiba, Tomonori Maeta, Kei Higaki, Kazunari Aoki, Hitomi Watanabe, Gen Kondoh, Riko Nishimura, Shu Takeda, Ung-il Chung, et al. Runx1 and Runx2 inhibit fibrotic conversion of cellular niches for hematopoietic stem cells. Nature Communications. 2022. 13. 1
Naokazu Nakamura, Fumiya Wada, Tadakazu Kondo, Kazunari Aoki, Yasuyuki Arai, Chisaki Mizumoto, Junya Kanda, Toshio Kitawaki, Kouhei Yamashita, Akifumi Takaori-Kondo. Significance of Omitting Day 11 Mini-Dose Methotrexate for GVHD Prophylaxis After Unrelated Bone Marrow Transplantation. Transplantation and Cellular Therapy. 2022
青木淳, 青木一成, 小沼貴晶, 土岐典子, 片山雄太, 内田直之, 澤正史, 鬼塚真仁, 松岡賢市, 神田善伸, et al. Impact of azacitidine pretreatment on outcomes of allo-HSCT in patients with high-risk MDS. 日本造血細胞移植学会総会プログラム・抄録集. 2020. 42nd
J. Aoki, T. Konuma, K. Aoki, K. Iwato, Y. Ozawa, Y. Kanda, K. Ohashi, N. Uchida, H. Kobayashi, M. Sawa, et al. IMPACT OF AZACITIDINE PRETREATMENT ON OUTCOMES OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH HIGH-RISK MYELODYSPLASTIC SYNDROME. HAEMATOLOGICA. 2017. 102. 134-134
H. Itonaga, K. Ishiyama, J. Aoki, K. Aoki, T. Ishikawa, N. Uchida, K. Ohashi, Y. Ueda, T. Fukuda, T. Ichinohe, et al. ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR PATIENTS AGED 60 YEARS OR OLDER WITH MYELODYSPLASTIC SYNDROME IN JAPAN. LEUKEMIA RESEARCH. 2017. 55. S26-S26
Hidehiro Itonaga, Kazunari Aoki, Jun Aoki, Ken Ishiyama, Takayuki Ishikawa, Kazuteru Ohashi, Takahiro Fukuda, Yukiyasu Ozawa, Naoki Kobayashi, Naoyuki Uchida, et al. Impact of Unbalanced Translocation Der(1;7)(q10;p10) and-7/Del(7q) on the Prognostic Value after Allogeneic Hematopoietic Stem Cell Transplantation in Myelodysplastic Syndromes: A Nationwide Retrospective Study. BLOOD. 2015. 126. 23
2023/07 - JSH International Symposium Best Session Award
2021/05 - Japanese Society of Myeloma Japanese Society of Myeloma Research Award
2020/10 - Japanese Society of Hematology 82nd Annual Meeting of the Japanese Society of Hematology Best Poster Award
2015/11 - 日本白血病研究基金 臨床医学特別賞
2015/10 - Japanese Society of Hematology JSH Encouragement Award
2013/03 - 神戸市立医療センター中央市民病院 後期研修医優秀賞
2012/12 - American Society of Hematology American Society of Hematology Abstract Achievement Award
Show all
Association Membership(s) (5)：
日本内科学会
, Japanese society of myeloma
, Japanese society for transplantation and cellular therapy
, Japanese Society of Hematology
, Japanese Cancer Association
